Abstract:BACKGROUND:Endometriosis is a benign gynaecological disease with malignant characteristics that severely affects women's quality of life. Long noncoding RNA maternally expressed gene 3 (LncRNA MEG3) is a tumour suppressor that is downregulated in various cancer cells and tissues, and regulates multiple biological processes. Emerging studies have revealed that the interactions between MEG3 and proteins are involved in disease progression. Galectin-1 affects cell motility, signal transduction and vascularization, and is overexpressed in endometriosis. Our study is the first to explore the role of MEG3-210 transcript in endometriosis and to reveal the regulatory mechanism mediated by the interaction between MEG3-210 and Galectin-1.MATERIALS AND METHODS:Endometrial tissues and sera from patients with endometriosis and controls were collected. qRT-PCR was performed to detect the expression of MEG3-210 in the endometrium and endometrial stromal cells (ESCs). The CCK-8 assay, the Transwell assay, flow cytometry and animal models were conducted to evaluate the functions of MEG3-210 in vitro and in vivo. Bioinformatic analysis, Western blot assays, RNA-pull down assays and RNA immunoprecipitation were used to explore the potential mechanism of MEG3-210 in endometriosis.RESULTS:Our results showed that MEG3-210 expression was lower in the eutopic endometrium of women with endometriosis. MEG3-210 downregulation promoted ESCs migration, invasion, anti-apoptosis in vitro and growth of endometriotic lesions in vivo. Furthermore, MEG3-210 downregulation could activate p38 mitogen-activated protein kinase (p38 MAPK) and inhibit cAMP-dependent protein kinase A/sarcoplasmic reticulum Ca2+ ATPase 2 (PKA/SERCA2) signalling, which was mediated by Galectin-1. The protein levels of Galectin-1 in patients with endometriosis were elevated, and Galectin-1 siRNA could reduce the size of lesions.CONCLUSION:MEG3-210 regulates ESCs through p38 MAPK and PKA/SERCA signalling via interaction with Galectin-1. The novel regulatory mechanism may provide new insights into drug therapy and the diagnosis of endometriosis.

Long Non-coding RNA MEG3 Attenuates the Angiotensin II-Induced Injury of Human Umbilical Vein Endothelial Cells by Interacting With p53

Long Noncoding RNA MEG3 Mediated Angiogenesis after Cerebral Infarction Through Regulating P53/nox4 Axis.

Knockdown of Long Noncoding RNA MEG3 Impairs VEGF-stimulated Endothelial Sprouting Angiogenesis Via Modulating VEGFR2 Expression in Human Umbilical Vein Endothelial Cells

LncRNA Meg3 protects endothelial function by regulating the DNA damage response

LncRNA MEG3-210 Regulates Endometrial Stromal Cells Migration, Invasion and Apoptosis Through P38 MAPK and PKA/SERCA2 Signalling Via Interaction with Galectin-1 in Endometriosis.

Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21

Long Non-Coding RNA MEG 3 Mediates High Glucose-Induced Endothelial Cell Dysfunction

Long Non‐coding RNA MEG3 Knockdown Attenuates Endoplasmic Reticulum Stress‐mediated Apoptosis by Targeting P53 Following Myocardial Infarction

Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway

GW29-e1836 Long Non-Coding RNA MEG3 Knockdown Attenuates Endoplasmic Reticulum Stress-Mediated Apoptosis by Targeting P53 after Myocardial Infarction

Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells.

LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases

Multifaceted roles of Meg3 in cellular senescence and atherosclerosis

Long non-coding RNA Meg3 deficiency impairs glucose homeostasis and insulin signaling by inducing cellular senescence of hepatic endothelium in obesity

Down‐Regulated Long Non‐Coding RNA MEG3 and Its Effect on Promoting Apoptosis and Suppressing Migration of Trophoblast Cells

Long Noncoding RNA Meg3 Regulates Cardiomyocyte Apoptosis in Myocardial Infarction

Abstract 341: Disturbance of p53-indcued Long Noncoding RNA Meg3-FUS Complex by AAV9 System Preserves Heart Function in Myocardial Infarction

Long Noncoding RNA MEG3 Silencing Protects Against Hypoxia-Induced Pheochromocytoma-12 Cell Injury Through Inhibition of TIMP2 Promoter Methylation.

Vitamin D ameliorated endothelial cell damage induced by diabetes via regulation of lncRNA MEG3 in human umbilical vein endothelial cells

Inhibitory Effects of Long Noncoding RNA MEG3 on Hepatic Stellate Cells Activation and Liver Fibrogenesis.

MicroRNA-384-mediated Herpud1 Upregulation Promotes Angiotensin II-induced Endothelial Cell Apoptosis.